Conotoxins: molecular and therapeutic targets

Area of Science:

• Marine biology
• Pharmacology
• Neuroscience

Background:

• Cone snails (gastropod molluscs) produce a diverse venom containing over 50,000 unique peptides.
• These conopeptides are evolutionarily adapted for prey capture and defense.
• Many conopeptides act as selective modulators of ion channels and transporters.

Purpose of the Study:

• To highlight the pharmacological potential of cone snail venom peptides.
• To underscore their value as ligands for studying ion channels and transporters in physiology and disease.
• To emphasize the therapeutic promise of conopeptides for pain management.

Main Methods:

• Review of existing literature on cone snail venom composition and function.
• Analysis of pharmacological characterization of conopeptides.
• Examination of pre-clinical and clinical development of conopeptide-based therapeutics.

Main Results:

• Over 50,000 conopeptides identified, with significant potential for modulating ion channels.
• A small fraction (<1%) of these peptides are pharmacologically characterized.
• Several conopeptides demonstrate analgesic properties in animal models, progressing to clinical trials for severe pain.

Conclusions:

• Cone snail venom represents a rich, largely untapped resource for novel pharmacological tools and therapeutics.
• Further characterization of conopeptides is crucial for unlocking their full therapeutic potential, particularly in pain management.
• Conopeptides are valuable for understanding ion channel function in health and disease.